UBS Group’s Global Medical REIT GMRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.66M | Buy |
383,544
+10,799
| +3% | +$74.8K | ﹤0.01% | 3594 |
|
|
2025
Q1 | $3.26M | Buy |
372,745
+88,358
| +31% | +$773K | ﹤0.01% | 3324 |
|
|
2024
Q4 | $2.2M | Sell |
284,387
-4,050
| -1% | -$31.3K | ﹤0.01% | 3651 |
|
|
2024
Q3 | $2.86M | Buy |
288,437
+3,906
| +1% | +$38.7K | ﹤0.01% | 2755 |
|
|
2024
Q2 | $2.58M | Buy |
284,531
+23,931
| +9% | +$217K | ﹤0.01% | 2626 |
|
|
2024
Q1 | $2.28M | Sell |
260,600
-3,741
| -1% | -$32.7K | ﹤0.01% | 2865 |
|
|
2023
Q4 | $2.93M | Buy |
264,341
+19,431
| +8% | +$216K | ﹤0.01% | 2506 |
|
|
2023
Q3 | $2.2M | Sell |
244,910
-7,892
| -3% | -$70.8K | ﹤0.01% | 2477 |
|
|
2023
Q2 | $2.31M | Sell |
252,802
-7,435
| -3% | -$67.9K | ﹤0.01% | 2576 |
|
|
2023
Q1 | $2.37M | Buy |
260,237
+13,687
| +6% | +$125K | ﹤0.01% | 2441 |
|
|
2022
Q4 | $2.34M | Buy |
246,550
+30,045
| +14% | +$285K | ﹤0.01% | 2445 |
|
|
2022
Q3 | $1.85M | Buy |
216,505
+31,286
| +17% | +$267K | ﹤0.01% | 2408 |
|
|
2022
Q2 | $2.08M | Sell |
185,219
-39,872
| -18% | -$448K | ﹤0.01% | 2360 |
|
|
2022
Q1 | $3.67M | Sell |
225,091
-25,673
| -10% | -$419K | ﹤0.01% | 2181 |
|
|
2021
Q4 | $4.45M | Sell |
250,764
-18,841
| -7% | -$334K | ﹤0.01% | 2199 |
|
|
2021
Q3 | $3.96M | Buy |
269,605
+73,447
| +37% | +$1.08M | ﹤0.01% | 2209 |
|
|
2021
Q2 | $2.9M | Buy |
196,158
+129,281
| +193% | +$1.91M | ﹤0.01% | 2435 |
|
|
2021
Q1 | $877K | Buy |
66,877
+41,903
| +168% | +$550K | ﹤0.01% | 3488 |
|
|
2020
Q4 | $326K | Sell |
24,974
-1,030
| -4% | -$13.4K | ﹤0.01% | 3966 |
|
|
2020
Q3 | $351K | Buy |
26,004
+8,174
| +46% | +$110K | ﹤0.01% | 3646 |
|
|
2020
Q2 | $202K | Sell |
17,830
-90,427
| -84% | -$1.02M | ﹤0.01% | 3998 |
|
|
2020
Q1 | $1.1M | Sell |
108,257
-42,032
| -28% | -$426K | ﹤0.01% | 2594 |
|
|
2019
Q4 | $1.99M | Sell |
150,289
-5,606
| -4% | -$74.2K | ﹤0.01% | 2766 |
|
|
2019
Q3 | $1.78M | Buy |
155,895
+4,660
| +3% | +$53.1K | ﹤0.01% | 2719 |
|
|
2019
Q2 | $1.59M | Buy |
151,235
+63,074
| +72% | +$662K | ﹤0.01% | 2695 |
|
|
2019
Q1 | $866K | Buy |
88,161
+6,428
| +8% | +$63.1K | ﹤0.01% | 3027 |
|
|
2018
Q4 | $726K | Buy |
81,733
+55,987
| +217% | +$497K | ﹤0.01% | 3241 |
|
|
2018
Q3 | $243K | Buy |
25,746
+6,202
| +32% | +$58.5K | ﹤0.01% | 4102 |
|
|
2018
Q2 | $173K | Buy |
19,544
+647
| +3% | +$5.73K | ﹤0.01% | 4207 |
|
|
2018
Q1 | $131K | Buy |
18,897
+457
| +2% | +$3.17K | ﹤0.01% | 4237 |
|
|
2017
Q4 | $151K | Sell |
18,440
-4,231
| -19% | -$34.6K | ﹤0.01% | 4189 |
|
|
2017
Q3 | $204K | Sell |
22,671
-9,616
| -30% | -$86.5K | ﹤0.01% | 3994 |
|
|
2017
Q2 | $289K | Buy |
32,287
+20,440
| +173% | +$183K | ﹤0.01% | 3693 |
|
|
2017
Q1 | $108K | Buy |
11,847
+1,477
| +14% | +$13.5K | ﹤0.01% | 4166 |
|
|
2016
Q4 | $93K | Buy |
+10,370
| New | +$93K | ﹤0.01% | 4455 |
|